Jinling Liu, Jing Song, Shasha Han, Yuanyuan Li, Ping Chen, Qian Liu, Na Liu, Min Wu
{"title":"LncRNA TINCR rs2288947 Polymorphism as a Genetic Susceptibility Factor for Diabetic Retinopathy.","authors":"Jinling Liu, Jing Song, Shasha Han, Yuanyuan Li, Ping Chen, Qian Liu, Na Liu, Min Wu","doi":"10.1155/joph/2631055","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long noncoding RNAs (lncRNAs) are critically involved in the pathogenesis of diabetic retinopathy (DR). Nevertheless, the role of lncRNA TINCR in DR has not been fully elucidated.</p><p><strong>Objective: </strong>This study aimed to examine the relationship between the lncRNA TINCR polymorphism rs2288947 and DR susceptibility in a Chinese Han population with Type 2 diabetes mellitus (T2DM) and to explore the diagnostic potential of plasma lncRNA TINCR levels.</p><p><strong>Methods: </strong>A case-control study was conducted with 507 participants (255 NPDR patients and 252 T2DM controls). Plasma TINCR expression was measured via qRT-PCR, and rs2288947 genotyping was performed using the TaqMan assay. Multivariate logistic regression and ROC analyses were applied to evaluate diagnostic value and risk associations.</p><p><strong>Results: </strong>LncRNA TINCR expression was significantly elevated and served as an independent risk factor in NPDR patients and exhibited high diagnostic value. The <i>G</i> allele of rs2288947 was associated with increased NPDR risk and higher lncRNA TINCR expression. Carriers of GA/GG genotypes showed upregulated lncRNA TINCR, which correlated with longer diabetes duration, elevated HbA1c, reduced HDL-C, and impaired renal function.</p><p><strong>Conclusion: </strong>Both lncRNA TINCR and the rs2288947 polymorphism contribute to NPDR development and show promise as biomarkers for early screening and risk evaluation.</p>","PeriodicalId":16674,"journal":{"name":"Journal of Ophthalmology","volume":"2026 ","pages":"2631055"},"PeriodicalIF":2.2000,"publicationDate":"2026-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13174572/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/joph/2631055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Long noncoding RNAs (lncRNAs) are critically involved in the pathogenesis of diabetic retinopathy (DR). Nevertheless, the role of lncRNA TINCR in DR has not been fully elucidated.
Objective: This study aimed to examine the relationship between the lncRNA TINCR polymorphism rs2288947 and DR susceptibility in a Chinese Han population with Type 2 diabetes mellitus (T2DM) and to explore the diagnostic potential of plasma lncRNA TINCR levels.
Methods: A case-control study was conducted with 507 participants (255 NPDR patients and 252 T2DM controls). Plasma TINCR expression was measured via qRT-PCR, and rs2288947 genotyping was performed using the TaqMan assay. Multivariate logistic regression and ROC analyses were applied to evaluate diagnostic value and risk associations.
Results: LncRNA TINCR expression was significantly elevated and served as an independent risk factor in NPDR patients and exhibited high diagnostic value. The G allele of rs2288947 was associated with increased NPDR risk and higher lncRNA TINCR expression. Carriers of GA/GG genotypes showed upregulated lncRNA TINCR, which correlated with longer diabetes duration, elevated HbA1c, reduced HDL-C, and impaired renal function.
Conclusion: Both lncRNA TINCR and the rs2288947 polymorphism contribute to NPDR development and show promise as biomarkers for early screening and risk evaluation.
期刊介绍:
Journal of Ophthalmology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the anatomy, physiology and diseases of the eye. Submissions should focus on new diagnostic and surgical techniques, instrument and therapy updates, as well as clinical trials and research findings.